Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology|June 17, 2020
Female Sexual Dysfunction: Pharmacologic and Therapeutic InterventionsLindsay J Wheeler, Saketh R Guntupalli
Gynecologic Oncology Reports|April 10, 2019
Clinical presentation of brain metastases from endometrial carcinoma: A case seriesMarisa R Moroney, Lindsay J Wheeler, Bradley R Corr
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2019
Pre-operative opioid use in gynecologic oncology: a common comorbidity relevant to the peri-operative periodMegan Elizabeth Ross, Lindsay J Wheeler, Dina M Flink, et al.
Gynecologic Oncology|October 18, 2017
PARP inhibitors: Clinical utility and possibilities of overcoming resistanceBenjamin G Bitler, Zachary L Watson, Lindsay J Wheeler, et al.
Obstetrics and Gynecology|September 11, 2019
Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysisLindsay J Wheeler, Kristen Desanto, Stephanie B Teal, et al.
Clinical Epigenetics|November 29, 2019
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinomaZachary L Watson, Tomomi M Yamamoto, Alexandra McMellen, et al.
Oncogenesis|November 28, 2018
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancerLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
JAMA Network Open|June 27, 2020
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm: A Randomized Clinical TrialSaketh R Guntupalli, Alyse Brennecke, Kian Behbakht, et al.
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Pageof 1